Peter C van Rijen Selected Research

Focal Cortical Dysplasia

10/2021	Balloon cells promote immune system activation in focal cortical dysplasia type 2b.
12/2019	Changes in vascular density in resected tissue of 97 patients with mild malformation of cortical development, focal cortical dysplasia or TSC-related cortical tubers.
3/2019	Long-term seizure outcome after epilepsy surgery in patients with mild malformation of cortical development and focal cortical dysplasia.
1/2019	Oxidative stress and inflammation in a spectrum of epileptogenic cortical malformations: molecular insights into their interdependence.
1/2019	Cognitive functioning after epilepsy surgery in children with mild malformation of cortical development and focal cortical dysplasia.
1/2014	Cell injury and premature neurodegeneration in focal malformations of cortical development.
1/2013	Differential expression of major histocompatibility complex class I in developmental glioneuronal lesions.
4/2011	Activation of Toll-like receptor, RAGE and HMGB1 signalling in malformations of cortical development.
12/2009	Doublecortin-like (DCL) expression in focal cortical dysplasia and cortical tubers.
6/2009	Expression patterns of synaptic vesicle protein 2A in focal cortical dysplasia and TSC-cortical tubers.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter C van Rijen Research Topics

Disease

17	Epilepsy (Aura) 01/2022 - 02/2004
13	Focal Cortical Dysplasia 10/2021 - 06/2003
11	Drug Resistant Epilepsy 01/2022 - 09/2003
11	Seizures (Absence Seizure) 01/2022 - 04/2009
11	Tuberous Sclerosis (Bourneville's Disease) 01/2022 - 06/2009
6	Temporal Lobe Epilepsy 10/2021 - 01/2006
5	Inflammation (Inflammations) 10/2021 - 01/2012
4	Malformations of Cortical Development 01/2014 - 11/2004
4	Ganglioglioma 01/2013 - 09/2003
3	Inborn Genetic Diseases (Disease, Hereditary) 01/2022 - 01/2017
3	Hippocampal Sclerosis 10/2021 - 01/2006
2	Intellectual Disability (Idiocy) 01/2022 - 01/2017
2	Rupture 01/2020 - 01/2016
1	Autism Spectrum Disorder 01/2022
1	Neurodevelopmental Disorders 10/2021
1	Status Epilepticus (Complex Partial Status Epilepticus) 10/2021
1	Arteriovenous Malformations (Arteriovenous Malformation) 01/2020
1	Hemimegalencephaly 01/2019
1	Encephalitis (Encephalitis, Rasmussen) 01/2019
1	Neuroinflammatory Diseases 01/2019
1	Autistic Disorder (Autism) 01/2017
1	Aneurysm (Aneurysms) 01/2016
1	Intracranial Aneurysm (Cerebral Aneurysm) 01/2016
1	Nervous System Diseases (Neurological Disorders) 01/2012
1	Paralysis (Palsy) 06/2010
1	Ganglioneuroma 06/2007
1	Neuroepithelial Neoplasms (Gliomatosis Cerebri) 11/2004
1	Neoplasms (Cancer) 09/2003

Drug/Important Bio-Agent (IBA)

9	trans-sodium crocetinate (crocetin)IBA 01/2022 - 06/2009
5	Anticonvulsants (Antiepileptic Drugs)IBA 12/2018 - 11/2009
3	mitomycin C-dextranIBA 12/2019 - 01/2019
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 09/2003
3	MicroRNAs (MicroRNA)IBA 01/2019 - 01/2012
2	AntioxidantsIBA 10/2021 - 01/2019
2	TOR Serine-Threonine KinasesIBA 10/2021 - 01/2014
2	Mechanistic Target of Rapamycin Complex 1IBA 10/2021 - 01/2017
2	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2016
1	Cell Adhesion MoleculesIBA 01/2022
1	Carrier Proteins (Binding Protein)IBA 01/2022
1	Circular RNAIBA 01/2022
1	IronIBA 10/2021
1	AntagomirsIBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	Interleukin-1beta (Interleukin 1 beta)IBA 01/2018
1	Immunoglobulins (Immunoglobulin)IBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 09/2015
1	Receptor for Advanced Glycation End ProductsIBA 04/2011
1	LigandsIBA 04/2011
1	HMGB1 Protein (HMG1)IBA 04/2011
1	Toll-Like Receptors (Toll-Like Receptor)IBA 04/2011
1	Toll-Like Receptor 2IBA 04/2011
1	Toll-Like Receptor 4IBA 04/2011
1	2- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA 06/2010
1	Vesicular Glutamate Transport Protein 1IBA 07/2009
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 06/2008
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2008
1	Immune Sera (Antisera)IBA 01/2006
1	Metabotropic Glutamate 5 ReceptorIBA 01/2006
1	2,6-dinitrotoluene (DNT)IBA 11/2004
1	Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA 11/2004
1	major vault proteinIBA 09/2003
1	N 30IBA 09/2003
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 06/2003

Therapy/Procedure

3	Therapeutics 10/2021 - 04/2009
3	Electrodes (Electrode) 06/2010 - 02/2004
1	Hemispherectomy 03/2011
1	Brain-Computer Interfaces 06/2010
1	Anterior Temporal Lobectomy 11/2009
1	Activities of Daily Living (ADL) 03/2007